Review of the Use of Liquid Chromatography-Tandem Mass Spectrometry in Clinical Laboratories: Part II- Operations

Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is increasingly utilized in clinical laboratories because it has advantages in terms of specificity and sensitivity over other analytical technologies. These advantages come with additional responsibilities and challenges given that many assays and platforms are not provided to laboratories as a single kit or device. The skills, staff, and assays used in LC-MS/MS are internally developed by the laboratory, with relatively few exceptions. Hence, a laboratory that deploys LC-MS/ MS assays must be conscientious of the practices and procedures adopted to overcome the challenges associated with the technology. This review discusses the post -development landscape of LC-MS/MS assays, including validation, quality assurance, operations, and troubleshooting. The content knowledge of LC-MS/MS users is quite broad and deep and spans multiple scientific fields, including biology, clinical chemistry, chromatography, engineering, and MS. However, there are no formal academic programs or specific literature to train laboratory staff on the fundamentals of LC-MS/MS beyond the reports on method development. Therefore, depending on their experience level, some readers may be familiar with aspects of the laboratory practices described herein, while others may be not. This review endeavors to assemble aspects of LC-MS/MS operations in the clinical laboratory to provide a framework for the thoughtful development and execution of LC-MS/ MS applications.

Automated summary

Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is widely used in clinical laboratories due to its advantages in specificity and sensitivity. However, there are challenges in terms of training laboratory staff and implementing the technology. This review aims to provide a framework for the development and execution of LC-MS/MS applications in clinical laboratories.